What are the potential benefits and risks of using anabolic therapies in frail patients with osteoporosis?

Anabolic therapies, including teriparatide, abaloparatide, and romosozumab, significantly reduce fracture risk and increase BMD in frail patients with osteoporosis but require careful cardiovascular risk assessment and consideration of cost and treatment accessibility.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-19
DOI
https://doi.org/10.5281/zenodo.24367212
Primary Topic
Bone health and osteoporosis research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

What are the potential benefits and risks of using anabolic therapies in frail patients with osteoporosis?

Tripdatabase
Zenodo (CERN European Organization for Nuclear Research)
Bone health and osteoporosis research
article

What are the potential benefits and risks of using anabolic therapies in frail patients with osteoporosis?

Tripdatabase
article en

Abstract

Anabolic therapies, including teriparatide, abaloparatide, and romosozumab, significantly reduce fracture risk and increase BMD in frail patients with osteoporosis but require careful cardiovascular risk assessment and consideration of cost and treatment accessibility.

Zenodo (CERN European Organization for Nuclear Research)
Bone health and osteoporosis research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon